Workflow
200 - day simple moving average (SMA)
icon
Search documents
EverQuote Trades Above 200-Day SMA: Time to Buy the Stock?
ZACKS· 2025-08-12 17:21
Core Insights - EverQuote, Inc. (EVER) is currently trading above its 200-day simple moving average (SMA), indicating a short-term bullish trend despite a recent price drop of 21.6% from its 52-week high of $30.03 [1][7] - The company has a market capitalization of $859.8 million and has seen its shares gain 7.7% year to date, underperforming compared to its industry and the broader market [2] Price Performance - EverQuote's share price as of Monday was $23.55, which is lower than the 52-week high [1] - The average volume of shares traded in the last three months was 0.4 million [2] Valuation Metrics - The price-to-book value of EverQuote is 4.94X, significantly higher than the industry average of 2.05X, indicating an expensive valuation [4] - Other multi-line insurers are trading at a discount to the industry average, suggesting a relative overvaluation for EverQuote [4] Growth Projections - EverQuote's return on equity (ROE) stands at 36.9%, well above the industry's 14.7%, reflecting strong operational efficiency [7][13] - The Zacks Consensus Estimate for EverQuote's 2025 earnings per share indicates a year-over-year increase of 47.7%, with revenues projected to reach $644.9 million, implying a 28.9% improvement [8] - Analysts have raised earnings estimates for 2025 and 2026, with a 10.2% increase for 2025 and a 5.7% increase for 2026 over the past week [9] Analyst Sentiment - The average price target from six analysts for EverQuote is $34 per share, suggesting a potential upside of 43.2% from the last closing price [10] Operational Insights - EverQuote is benefiting from rising consumer quote requests and is focused on enhancing platform capabilities and expanding data assets to attract more consumers [14] - The company anticipates strong revenue growth in its health direct-to-consumer agency during the annual health open enrollment period [15] Challenges - Despite positive momentum, EverQuote faces rising expenses due to increased costs in revenues, sales and marketing, R&D, and G&A [16] - The company operates in a competitive market with potential regulatory risks that could impact revenue and growth [16][17]
FCX Trades at Premium Valuation: Buy, Sell or Hold the Stock?
ZACKS· 2025-02-27 13:55
Core Viewpoint - Freeport-McMoRan Inc. (FCX) is facing challenges due to declining copper prices, high production costs, and downward revisions in earnings estimates, despite having strong financial health and ongoing expansion projects [2][21]. Financial Performance - FCX is currently trading at a forward price/earnings ratio of 21.65X, which is approximately 10% higher than the Zacks Mining - Non Ferrous industry average of 19.77X [1]. - The stock has experienced a 15.7% decline in share price over the past six months, underperforming the industry's decline of 15.3% and the S&P 500's rise of 6.4% [2]. - Operating cash flows for FCX were around $1.4 billion in Q4 2024, with full-year 2024 cash flows climbing 35% year over year to $7.2 billion [15]. Production and Expansion - FCX is focused on expanding its production capacity, with significant projects underway, including a concentrator expansion at Cerro Verde in Peru, which is expected to add 600 million pounds of copper annually [12]. - The company is also evaluating a large-scale expansion at El Abra in Chile and conducting pre-feasibility studies in Arizona to define significant sulfide expansion opportunities [12]. Cost and Pricing Challenges - FCX's consolidated unit net cash costs per pound of copper increased by 9% year over year in Q4 2024, with expectations for further increases in 2025 [18]. - Copper prices fell nearly 12% in Q4 2024, closing at around $4 per pound, influenced by weak demand in China and uncertainties regarding U.S. tariffs [20]. Market Sentiment and Valuation - The Zacks Consensus Estimate for FCX's earnings has been revised downward over the past 60 days, reflecting negative sentiment in the market [9]. - Despite strong financial health, the premium valuation of FCX may not present a compelling investment opportunity at current levels [11]. Dividend and Shareholder Value - FCX offers a dividend yield of approximately 0.8%, with a payout ratio of 20%, indicating a sustainable dividend policy [17]. - The company has distributed $4.7 billion to shareholders through dividends and share purchases since June 30, 2021 [15].